OptimizeRx Corporation (OPRX) NASDAQ
5.23
-0.15(-2.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.23
-0.15(-2.79%)
Currency In USD
| Market Cap | 227.49M |
| Enterprise Value | 230.23M |
| P/E Ratio | 14.37 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.92 |
| Price/Book Ratio | 0.76 |
| Enterprise/Revenue | 0.95 |
| Enterprise/EBITDA | 5.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.06 |
| Operating Margin | 0.14 |
| Return On Assets | 0.04 |
| Return On Equity | 0.05 |
| Revenue | 109.43M |
| Revenue/Share | 5.72 |
| Gross Profit | 69.27M |
| EBITDA | 16.39M |
| Net Income | 5.13M |
| Diluted EPS | 0.27 |
| Total Cash | 20.17M |
| Total Cash/Share | 1.08 |
| Total Debt | 23.72M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 5.37 |
| Book Value Per Share | 6.91 |
| 52-Week Change | -57.65 |
| 52-Week High | 22.25 |
| 52-Week Low | 4.57 |
| Moving Average 50 Days | 6.14 |
| Moving Average 200 Days | 12.29 |
| Average Volume | 531,928 |
| Shares Outstanding | 18.77M |
| % Held by Institutions | 73 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | May 14, 2018 |